CALL TOLL FREE:
FAX  TOLL  FREE:
1.866.930.3784
5:30 AM - 8:00 PM (M-F)
7:00 AM - 3:30 PM (S/S)

Lumigan (Bimatoprost)

Type
Product
Manufacturer
Country
Dosage
Qty-Price (USD)
Type: drug type
Product: Lumigan
Manufacturer: Allergan
Country: Canada
Dosage: 0.01 %/5 ml
Qty-Price (USD):
Type: drug type
Product: Lumigan
Manufacturer: Allergan
Country: Canada
Dosage: 0.01 %/7.5 ml
Qty-Price (USD):
Type: drug type
Product: Lumigan
Manufacturer: Allergan
Country: India
Dosage: 0.01 %/3 ml
Qty-Price (USD):
Type: drug type
Product: Lumigan
Manufacturer: Allergan
Country: United Kingdom
Dosage: 0.01 %/3 ml
Qty-Price (USD):
Type: drug type
Product: Lumigan
Manufacturer: Allergan
Country: India
Dosage: 0.03 %/3 ml
Qty-Price (USD):
Type: drug type
Product: Lumigan
Manufacturer: Abbvie
Country: India
Dosage: 0.03 %/3 ml
Qty-Price (USD):

Generic Equivalent of Lumigan
Type
Product
Manufacturer
Country
Dosage
Qty-Price (USD)
Type: drug type
Product: Bimatoprost
Manufacturer: Generic
Country: India
Dosage: 0.01 %/3 ml
Qty-Price (USD):
Type: drug type
Product: Bimatoprost
Manufacturer: Generic
Country: India
Dosage: 0.03 %/3 ml
Qty-Price (USD):

Lumigan online Canadian Pharmacy

Lumigan Information

portrait medically reviewed by Carol Hou (BSc. Pharm) on June 25, 2025.
A licensed pharmacist (Licensed Community Pharmacies Directory | College of Pharmacists of British Columbia) with over 20 years of experience in medication management, specifically medication safety, she has reviewed the information for accuracy and completeness.

LUMIGAN and Bimatoprost at CanadaPharmacyOnline.com

The brand name LUMIGAN (bimatoprost) is primarily manufactured by Allergan (now part of AbbVie). It is widely available in many countries, including Canada, India, the United Kingdom, and the United States.

Generic bimatoprost is sourced from manufacturers that meet applicable regulatory standards. The specific manufacturer of your dispensed medication may vary.

Important Information about Generic Bimatoprost:

Generic bimatoprost contains the same active ingredient as brand-name LUMIGAN and is required to meet the same safety, effectiveness, and quality standards. This means it is designed to work in the same way as LUMIGAN. Studies have shown that generic bimatoprost is bioequivalent to brand-name LUMIGAN, meaning they have similar absorption rates and reach similar concentrations in the bloodstream. However, individual responses to medication can vary due to factors such as metabolism, genetics, and other health conditions.

For more information about generic drug approval and bioequivalence, you can visit the FDA website: https://www.fda.gov/drugs/generic-drugs/generic-drug-facts

Dosage:

LUMIGAN (brand name) and bimatoprost (generic name) are both available as ophthalmic solutions (eye drops). They are typically available in strengths of 0.01% and 0.03%. While exact packaging sizes can vary by manufacturer and region, common bottle sizes include 3 mL, 5 mL, and 7.5 mL (at this pharmacy).

Your doctor will determine the appropriate dose based on your individual needs and medical conditions.

Usage:

LUMIGAN (bimatoprost) is a prescription medication to manage elevated pressure inside the eye in adults with open-angle glaucoma or ocular hypertension by improving fluid drainage. LUMIGAN eye drops can be used alone or together with other eye drops.

Mechanism of Action:
LUMIGAN (bimatoprost) lowers intraocular pressure (IOP) by increasing the outflow of aqueous humor from the eye. Its primary mechanism is through increasing uveoscleral outflow, but it also enhances trabecular meshwork outflow to a clinically relevant extent.

Use LUMIGAN exactly as your doctor prescribes, following the instructions in the product monograph in Canada. Consult your doctor for personalized guidance and safe use.

The information below summarizes some, but not all, potential side effects, risks, and interactions. Before taking LUMIGAN, it is essential to discuss all possible side effects, risks, and interactions with your doctor or pharmacist.

Side Effects:

The information below outlines potential side effects associated with LUMIGAN (bimatoprost). It is not an exhaustive list, and individual reactions can vary.

Common side effects

These are some common side effects of LUMIGAN, but others are possible. Contact your doctor promptly if any side effects are persistent, worsening, or concerning, or if you experience any other concerning symptoms.

These side effects may affect more than 1 in 100 people:

Eye-related:
• Eye irritation
• Dry eyes
• Feeling of something in the eye
• Increased growth of eyelashes
• Itching of the eye (eye pruritus)
• Redness of the eye (conjunctival hyperemia)
• Temporary blurred vision
• Watery eyes

Skin-related:
• Darkening of the skin around the eye (periocular skin hyperpigmentation)
• Eyelid redness (eyelid erythema)
• Increased hair growth on the eyelids (hypertrichosis)

Other:
• Headache

Less Common Side Effects:

These side effects may affect between 1 in 100 and 1 in 1,000 people:

Eye-related:
• Bleeding of the conjunctiva (conjunctival hemorrhage).
• Changes in the color of the iris (increased brown pigmentation), which may be permanent
• Corneal erosion
• Double vision
• Eye pain
• Eye discharge
• Eye strain
• Increased tearing
• Darkening of eyelashes
• Eyelid changes (e.g., deepening of the eyelid crease, drooping eyelid, tighter skin around the eye)
• Halos around lights
• Increased sensitivity of the eyes to sunlight
• Inflammation of the eyelid (blepharitis)
• Inflammation inside the eye (iritis, uveitis)
• Sensitivity to light (photophobia)
• Swelling of the conjunctiva (conjunctival edema)
• Tunnel vision
• Vision changes

Skin-related:
• Itching
• Rash

Respiratory:
• Asthma or worsening of asthma
• Difficulty breathing

Other:
• Body aches or pain
• Cough
• Dizziness
• Ear congestion
• Fever or chills
• Loss of voice
• Nasal congestion
• Runny nose
• Sneezing
• Sore throat
• Unusual tiredness or weakness

Rare but Serious Side Effects:

• Severe allergic reaction (anaphylaxis) with symptoms such as:
o Swelling of the lips, mouth, throat, or tongue
o Difficulty breathing or wheezing
o Tightness in the throat
o Dizziness or fainting
o Rash that is swollen, raised, itchy, blistered, or peeling
• Severe eye pain, redness, swelling, crusting, or drainage (may be signs of infection)
• Significant vision changes

Long-Term Side Effects:

Some side effects may be long-term or even permanent:

• Changes to eyelashes: Increased length, thickness, and darkness of eyelashes are usually reversible upon discontinuation, but in some cases, darkening may persist.
• Changes to the skin around the eye: Darkening of the eyelid skin may occur, which is usually mild and may disappear if the medication is stopped.
• Increased brown pigmentation of the iris: This change may be permanent.
• Loss of fat around the eye: This can lead to a deeper eyelid crease, sunken appearance of the eye, drooping eyelid, tighter skin around the eye, and more of the lower white part of the eye showing. These changes are usually mild and may disappear if the medication is stopped. These changes can be more noticeable in some individuals and may not be fully reversed.

Contraindications:

The following is not an exhaustive list of contraindications. Before starting LUMIGAN, it is crucial to discuss all your medical conditions, past and present, and all medications you are taking with your doctor or pharmacist.

LUMIGAN should not be used if:
• You are allergic to bimatoprost or any other ingredients in this medication

Tell your doctor about your medical conditions, past and present, before starting LUMIGAN. This is crucial because certain conditions affect whether LUMIGAN is right for you. These conditions may include, but are not limited to:
• Active intraocular inflammation, such as uveitis or iritis. Bimatoprost should be used with caution in patients with active intraocular inflammation, as it may exacerbate these conditions. The decision to use it should be made by the prescribing physician after careful consideration of the risks and benefits.
• Active ocular viral infections, such as active herpes simplex keratitis.
• Aphakia: absence of the natural lens in the eye.
• Dry eye: Bimatoprost formulations containing benzalkonium chloride, a common preservative, may exacerbate preexisting dry eyes. Preservative-free formulations of bimatoprost may be a better option for patients with significant dry eyes. Caution should be exercised, and the choice of formulation should be discussed with the prescribing physician.
• Compromised respiratory function, such as asthma or COPD, as there have been reports of exacerbation of these conditions.
• Known risk factors for macular edema include prior intraocular surgery, retinal vein occlusions, ocular inflammatory disease, or diabetic retinopathy.
• Predisposition to low heart rate or low blood pressure: Due to the potential for minor systemic absorption, patients with a predisposition to low heart rate or low blood pressure should use bimatoprost with caution and have their physician monitor them.
• Pseudophakia with a torn posterior lens capsule: presence of an artificial lens with a tear in the back part of the lens capsule.
• Renal or hepatic impairment: Bimatoprost has not been specifically studied in patients with significant renal or hepatic impairment.
Caution should be exercised when using this medication in these populations, and close monitoring may be necessary.
• Significant cardiovascular disease: Caution should be exercised in patients with significant cardiovascular disease, particularly those with heart block more severe than first degree or uncontrolled congestive heart failure, due to the potential for minimal systemic absorption. These patients should be monitored closely by their physician.

Drug Interactions:

Before taking LUMIGAN, it is essential to discuss all potential risks and interactions with your doctor or pharmacist. For complete and up-to-date information, refer to the LUMIGAN prescribing information | MedSafe.

Provide your doctor with a complete list of all your medications, including prescriptions, over-the-counter (OTC) drugs, vitamins, and herbal supplements. It is also important to inform your doctor about any herbal teas, recreational drugs, or significant dietary changes you are making, as these could potentially interact with LUMIGAN. LUMIGAN may interact with other medicines, but is not limited to:
• Hypotensive agents: LUMIGAN might increase the hypotensive effects of medications that lower blood pressure, such as acebutolol, aliskiren, amlodipine, benazepril, betaxolol, and others. This could lead to low blood pressure.
• Nonsteroidal anti-inflammatory drugs (NSAIDs): Nonsteroidal anti-inflammatory drugs (NSAIDs): While some studies have explored potential interactions between NSAIDs and prostaglandin analogs regarding intraocular pressure, clinically significant interactions are not well-established. However, it is still important to inform your doctor about all medications you are taking.
• Other prostaglandin analogs: Using LUMIGAN with other prostaglandin analogs for glaucoma, such as latanoprost, latanoprostene bunod, tafluprost, travoprost, and unoprostone, may decrease the effectiveness of both medications or increase the risk of side effects.

Pregnancy and Breastfeeding

Adequate and well-controlled human studies have not established the safety of LUMIGAN (bimatoprost) during pregnancy. Animal studies have shown adverse effects on the fetus. LUMIGAN should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, and this decision should be made in consultation with a healthcare professional.

Frequently Asked Questions about LUMIGAN at Canada Pharmacy Online:

Why is LUMIGAN more affordable in Canada than in the United States?

Prescription drug prices, including LUMIGAN, are generally lower in Canada than in the US due to a combination of factors, primarily government price regulations, differing market dynamics, and other economic considerations. In Canada, provincial and federal governments negotiate drug prices with pharmaceutical companies, which often results in lower costs compared to the U.S., where market forces play a more significant role. For more information, see the FAQs on Prescription Drug Importation from the Kaiser Family Foundation (KFF): https://www.kff.org/health-costs/issue-brief/faqs-on-prescription-drug-importation/

How much is the shipping?

Our shipping fee is a flat rate of $10.00 per order. Our pharmacy focuses on offering you the lowest prices on high-quality products.

How do I order from your pharmacy?

Ordering from us is very simple. You can purchase online or call Customer Service at 1866.920.3784; for more information or to learn about the ordering process, visit our How to Order page.

Is there a limit on how many bottles I am allowed to order at one time?

CanadaPharmacyOnline.com can only dispense a maximum of a three-month supply of LUMIGAN at once, per your doctor's prescription.

Can I buy over the counter from you?

No, LUMIGAN requires a valid prescription from your doctor. We do not sell this product without a valid prescription.

Do you ship to the United States?

Yes, we do. It usually takes 7 to 18 business days to receive your order from our pharmacy.

Is there a generic for LUMIGAN?

Yes, there is a generic alternative for this product called bimatoprost ophthalmic solution.

Can LUMIGAN make my eyelashes grow?

Yes, LUMIGAN can cause your eyelashes to become longer, thicker, and darker. These changes are usually reversible if you stop using the medication, although in some cases, darkening may persist.

How should I store LUMIGAN?

Store LUMIGAN at room temperature, away from heat and light. Do not freeze. Keep the bottle tightly closed when not in use. Keep out of reach of children.

Blog Post

Glaucoma in Dogs and How Azopt and other Hero Eye Drops Help

Latest News

GLP-1 Receptor Agonists Could Reduce Risk of Glaucoma in Type 2 Diabetes (article published on June 18, 2025)

Similar Drugs in the category of Glaucoma Medications:

   Vyzulta    Combigan    Azopt Drops    Travatan Opht Sol 0.004%    Xalatan Eye Drops

The information on this page is sourced from independent third parties contracted by CanadaPharmacyOnline. While we cannot guarantee its medical accuracy, we strongly recommend consulting a healthcare professional for personalized advice regarding medications or medical conditions.

Reviews From Real Customers
Drug Categories


Top Products

Prescriptions Dispensed from Canada are Dispensed by Candrug Pharmacy #18985. 202A 8322-130th Street, Surrey, British Columbia, Canada V3W 8J9, 604-543-8711. Pharmacy Manager: Carol Hou.
This pharmacy is duly licensed in the province of British Columbia, Canada by the College of Pharmacists of BC. If you have any questions or concerns you can contact the college at: 200-1765 West 8th Ave Vancouver, BC V6J 5C6 Canada.
All prices are in US dollars.
© Copyright 2006 - 2025 Canada Pharmacy Online. All Rights Reserved.